regeneron dna - Search News

Order byBest matchMost fresh

DNA, 23andMe and Regeneron

23andMe sells its most valuable asset. Regeneron promises keep your DNA private.

Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Holding Co.

· 16h · on MSN

Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA data

· 8h · on MSN

23andMe To Be Sold in Bankruptcy: What It Means for Your DNA Data

Biotechnology company Regeneron buying 23andMe for $256 million

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

· 11h

· 13h

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

· 17h

Bankrupt DNA testing company 23andMe to be bought by Regeneron

16h

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.

13hon MSN

Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions

It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly handed over the samples to completely different owners.

Stocktwits on MSN17h

Regeneron To Buy Assets Of 23andMe For $256M: Retail Says ‘Fantastic’ For Future R&D Efforts

Drugmaker Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that it will acquire the assets of bankrupt biotechnology company 23andMe Holding Co. for $256 million. Regeneron intends to acquire 23andMe’s Personal Genome Service (PGS),